Cosette Pharmaceuticals Acquires Mayne Pharma
The Dermatology Digest
FEBRUARY 21, 2025
Cosette Pharmaceuticals, Inc. Upon close, Cosette will market 12 patent-protected products focused on womens health and dermatology, including leading brands such as Rhofade (oxymetazoline topical)and several programs in clinical development. is acquiring Mayne Pharma.
Let's personalize your content